Women : Estrogen upregulates IGF-1, so women tend to get outsized benefit from sermorelin's lower dose making tesamorelin's higher intensity more aggressive than most women need
The straightforward answer is: maybe
In NCI-H716 human enteroendocrine cells, tetrapeptides, but not single amino acids or any of the dipeptides, tripeptides and pentapeptides tested, were found to induce a robust and selective [Ca 2+ ] i response associated with increased secretion of GLP-1 (Reference Le Nev and Daniel81)
The medication is not directly causing the urination, but it is creating the conditions that lead to it
Depending on how well your body tolerates the medication, your dose will gradually step up to 4mg, then 9mg, and eventually up to the maximum maintenance dose of 25mg daily